REVLIMID

Identification of Revlimid

No description

Google image searchProduct monograph

Active ingredient

lenalidomide, 25 MG

DIN: 02317710

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: BRISTOL-MYERS SQUIBB CANADA

Date: 09-FEB-2024

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AX — Other immunosuppressants (ATC, ATC/DDD)
• L04AX04 — LENALIDOMIDE (ATC/DDD)

Reference brand drug: Revlimid

Pharmaceutical standard: MFR

External Links for Revlimid

Search on Google

• Revlimid side effects
• Revlimid dosage
• lenalidomide side effects
• lenalidomide dosage

Bristol-Myers Squibb Canada

Go to Bristol-Myers Squibb website to see drug product details. Sometimes you can find revlimid photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.